Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis - PubMed (original) (raw)
Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis
Han-Chieh Wu et al. Hum Pathol. 2014 Jun.
Abstract
Hepatitis B virus (HBV) X protein (HBx) and pre-S2 deletion mutant large surface antigens are oncoproteins that induce hepatocellular carcinoma (HCC). The interaction of these two oncoproteins in hepatocytes and its significance in tumorigenesis remain to be elucidated. In this study, we observed the co-expression of HBx with surface antigens in ground-glass hepatocytes in 5 of 20 hepatitis B surface antigen-positive livers. In vitro, hepatocytes co-expressing HBx and a pre-S2 mutant showed enhanced expression of vascular endothelial growth factor-A, phosphorylated Akt 1/2/3, phosphorylated extracellular signal-regulated kinase 1/2, and phosphorylated mammalian target of rapamycin signals. Transgenic mice harboring both HBx and pre-S2 mutant construct plasmids developed HCCs at an average of 15.1 months, earlier than animals carrying either HBx (16.9 months) or pre-S2 mutant (24.5 months) alone. The oncogenic signals of vascular endothelial growth factor-A, phosphorylated Akt 1/2/3, phosphorylated extracellular signal-regulated kinase 1/2, and phosphorylated mammalian target of rapamycin were sequentially and differentially activated at different stages in tumorigenesis. Phosphorylated mTOR was consistently activated in transgenic and human HCCs. We conclude that ground-glass hepatocytes co-expressing HBx and surface antigens exhibit enhanced oncogenic effects and tumorigenesis in chronic HBV infections. The mTOR signal cascade may be the key regulator in HBV tumorigenesis and may be useful targets in the design of HCC therapy.
Keywords: Ground-glass hepatocytes; HBx; Hepatocellular carcinoma; Pre-S2 deletion mutant; mTOR signals.
Copyright © 2014. Published by Elsevier Inc.
Similar articles
- The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.
Su IJ, Wang LH, Hsieh WC, Wu HC, Teng CF, Tsai HW, Huang W. Su IJ, et al. J Biomed Sci. 2014 Oct 15;21(1):98. doi: 10.1186/s12929-014-0098-7. J Biomed Sci. 2014. PMID: 25316153 Free PMC article. Review. - Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH, Chang YY, Su IJ, Yen CJ, Liu YR, Liu RJ, Hsieh WC, Tsai HW, Wang LH, Huang W. Hsieh YH, et al. J Pathol. 2015 Jul;236(3):337-47. doi: 10.1002/path.4531. Epub 2015 Apr 22. J Pathol. 2015. PMID: 25775999 - Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. Hsieh YH, et al. Carcinogenesis. 2004 Oct;25(10):2023-32. doi: 10.1093/carcin/bgh207. Epub 2004 Jun 3. Carcinogenesis. 2004. PMID: 15180947 - Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH, Su IJ, Yen CJ, Tsai TF, Tsai HW, Tsai HN, Huang YJ, Chen YY, Ai YL, Kao LY, Hsieh WC, Wu HC, Huang W. Hsieh YH, et al. Carcinogenesis. 2013 Feb;34(2):475-85. doi: 10.1093/carcin/bgs365. Epub 2012 Nov 21. Carcinogenesis. 2013. PMID: 23172669 - Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.
Su IJ, Wang HC, Wu HC, Huang WY. Su IJ, et al. J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1169-74. doi: 10.1111/j.1440-1746.2008.05348.x. Epub 2008 May 26. J Gastroenterol Hepatol. 2008. PMID: 18505413 Review.
Cited by
- The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.
Su IJ, Wang LH, Hsieh WC, Wu HC, Teng CF, Tsai HW, Huang W. Su IJ, et al. J Biomed Sci. 2014 Oct 15;21(1):98. doi: 10.1186/s12929-014-0098-7. J Biomed Sci. 2014. PMID: 25316153 Free PMC article. Review. - Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Teng CF, Wu HC, Shyu WC, Jeng LB, Su IJ. Teng CF, et al. Cell Transplant. 2017 Mar 13;26(3):429-438. doi: 10.3727/096368916X694382. Epub 2017 Feb 14. Cell Transplant. 2017. PMID: 28195035 Free PMC article. Review. - Hepatocellular carcinoma and hepatitis B surface protein.
Li YW, Yang FC, Lu HQ, Zhang JS. Li YW, et al. World J Gastroenterol. 2016 Feb 14;22(6):1943-52. doi: 10.3748/wjg.v22.i6.1943. World J Gastroenterol. 2016. PMID: 26877602 Free PMC article. Review. - Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
Chang TS, Chen CL, Wu YC, Liu JJ, Kuo YC, Lee KF, Lin SY, Lin SE, Tung SY, Kuo LM, Tsai YH, Huang YH. Chang TS, et al. PLoS One. 2016 Feb 26;11(2):e0149897. doi: 10.1371/journal.pone.0149897. eCollection 2016. PLoS One. 2016. PMID: 26919045 Free PMC article. - Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant.
Teng CF, Li TC, Wang T, Liao DC, Wen YH, Wu TH, Wang J, Wu HC, Shyu WC, Su IJ, Jeng LB. Teng CF, et al. Sci Rep. 2021 Jan 13;11(1):1136. doi: 10.1038/s41598-020-80935-5. Sci Rep. 2021. PMID: 33441885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous